I am referring to US pharma deals between 2018 and 2023. Of course those valuations aren't applied here. The ASX values income, that means sp at 0.1c and almost zero to potential and progress.
In the end, only $ do the talking. Thanks to that attitude some of us were able to lay the foundation for a nice fortune in coming years.
GLTA
I am referring to US pharma deals between 2018 and 2023. Of...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $50.77K | 12.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2602327 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18629873 | 23 |
View Market Depth
| Last trade - 15.15pm 25/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |